Mark Farrugia

1.2k total citations
69 papers, 745 citations indexed

About

Mark Farrugia is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology and Oncology. According to data from OpenAlex, Mark Farrugia has authored 69 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 22 papers in Otorhinolaryngology and 20 papers in Oncology. Recurrent topics in Mark Farrugia's work include Head and Neck Cancer Studies (22 papers), Lung Cancer Diagnosis and Treatment (13 papers) and Oral health in cancer treatment (11 papers). Mark Farrugia is often cited by papers focused on Head and Neck Cancer Studies (22 papers), Lung Cancer Diagnosis and Treatment (13 papers) and Oral health in cancer treatment (11 papers). Mark Farrugia collaborates with scholars based in United States, United Kingdom and Australia. Mark Farrugia's co-authors include Anurag K. Singh, J. Michael Ruppert, Sung Jun, Austin J. Iovoli, Mohamad A. Salkeni, Sarah L. McLaughlin, Han Yu, Chen‐Chung Lin, Chad J. Creighton and Kathleen M. Brundage and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mark Farrugia

63 papers receiving 738 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Farrugia United States 15 277 234 172 161 119 69 745
Moon‐Sing Lee Taiwan 19 243 0.9× 213 0.9× 225 1.3× 223 1.4× 122 1.0× 65 961
Rangesh Kunnavakkam United States 17 420 1.5× 163 0.7× 249 1.4× 209 1.3× 160 1.3× 29 800
Shaleen Kumar India 15 230 0.8× 165 0.7× 105 0.6× 190 1.2× 87 0.7× 53 695
Michelle Echevarria United States 9 252 0.9× 91 0.4× 253 1.5× 117 0.7× 89 0.7× 30 561
C. Nutting United Kingdom 15 284 1.0× 96 0.4× 145 0.8× 89 0.6× 80 0.7× 34 679
Sandra Ventorin von Zeidler Brazil 11 174 0.6× 141 0.6× 177 1.0× 265 1.6× 76 0.6× 32 801
Yanming Jiang China 16 100 0.4× 106 0.5× 173 1.0× 161 1.0× 71 0.6× 68 680
Jeffrey Straub United States 3 114 0.4× 87 0.4× 126 0.7× 159 1.0× 48 0.4× 7 486
Jerzy Wydmański Poland 15 312 1.1× 70 0.3× 247 1.4× 196 1.2× 48 0.4× 76 721
Olgun Eliçin Switzerland 17 374 1.4× 85 0.4× 218 1.3× 246 1.5× 83 0.7× 75 875

Countries citing papers authored by Mark Farrugia

Since Specialization
Citations

This map shows the geographic impact of Mark Farrugia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Farrugia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Farrugia more than expected).

Fields of papers citing papers by Mark Farrugia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Farrugia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Farrugia. The network helps show where Mark Farrugia may publish in the future.

Co-authorship network of co-authors of Mark Farrugia

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Farrugia. A scholar is included among the top collaborators of Mark Farrugia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Farrugia. Mark Farrugia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farrugia, Mark, Elizabeth A. Repasky, Minhui Chen, et al.. (2025). Prognostic immune markers in esophageal cancer patients managed with trimodal therapy. Cancer Immunology Immunotherapy. 74(2). 57–57. 1 indexed citations
2.
Singh, Anurag Kumar, et al.. (2025). Novel pre‐spatial data fusion deep learning approach for multimodal volumetric outcome prediction models in radiotherapy. Medical Physics. 52(4). 2675–2687. 1 indexed citations
3.
Iovoli, Austin J., Kelsey M. Smith, Han Yu, et al.. (2024). Association of Insomnia and Obstructive Sleep Apnea with Worse Oral Mucositis and Quality of Life in Head and Neck Cancer Patients Undergoing Radiation Therapy. Cancers. 16(7). 1335–1335. 4 indexed citations
4.
Iovoli, Austin J., Mark Farrugia, Kimberly Wooten, et al.. (2024). Association of low adherence to weekly cisplatin with outcomes in patients with head and neck squamous cell carcinoma: a retrospective cohort study. BMC Cancer. 24(1). 838–838. 1 indexed citations
5.
Jun, Sung, Han Yu, Austin J. Iovoli, et al.. (2023). Association of neutrophil–lymphocyte ratio with survival in peripheral early-stage non-small cell lung cancer after stereotactic body radiation therapy. BMC Cancer. 23(1). 254–254. 5 indexed citations
6.
7.
Iovoli, Austin J., Sung Jun, Nadia Malik, et al.. (2023). Long-Term Survival and Failure Outcomes of Single-Fraction Stereotactic Body Radiation Therapy in Early Stage NSCLC. JTO Clinical and Research Reports. 4(12). 100598–100598. 1 indexed citations
8.
Iovoli, Austin J., et al.. (2023). Prophylactic High-Dose Gabapentin Reduces Opiate Use during Radiation Therapy for Head and Neck Squamous Cell Carcinoma. Cancers. 15(7). 2003–2003. 2 indexed citations
9.
Yu, Brian, Sung Jun, Austin J. Iovoli, et al.. (2023). Association of pretreatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiation.. Journal of Clinical Oncology. 41(16_suppl). 6052–6052. 1 indexed citations
10.
Jun, Sung, Austin J. Iovoli, Katy Wang, et al.. (2023). Efficacy of Prophylactic High-Dose Gabapentin and Venlafaxine on Reducing Oral Mucositis Pain Among Patients Treated With Chemoradiation for Head and Neck Cancer: A Single-Institution, Phase 2, Randomized Clinical Trial. International Journal of Radiation Oncology*Biology*Physics. 116(4). 797–806. 5 indexed citations
11.
Iovoli, Austin J., et al.. (2022). Quality of Life After Stereotactic Body Radiation Therapy or Surgery for Early-Stage NSCLC: A Systematic Review. JTO Clinical and Research Reports. 3(11). 100417–100417. 7 indexed citations
12.
Iovoli, Austin J., H Malhotra, Nadia Malik, et al.. (2022). Brachial Plexopathy After Single-Fraction Stereotactic Body Radiation Therapy in Apical Lung Tumors. Practical Radiation Oncology. 13(3). e246–e253. 4 indexed citations
13.
Shaver, Amy L., Anna E. Płatek, Anurag K. Singh, et al.. (2022). Effect of musculature on mortality, a retrospective cohort study. BMC Cancer. 22(1). 688–688. 5 indexed citations
14.
Kao, Johnny, et al.. (2021). Association of radiation dose intensity with overall survival in patients with distant metastases. Cancer Medicine. 10(22). 7934–7942. 7 indexed citations
15.
16.
Farrugia, Mark, Han Yu, Anurag K. Singh, & H Malhotra. (2021). Autosegmentation of cardiac substructures in respiratory-gated, non-contrasted computed tomography images. World Journal of Clinical Oncology. 12(2). 95–102. 9 indexed citations
17.
Farrugia, Mark, et al.. (2021). A Dose-Response Relationship to Radiotherapy for Cutaneous Lesions of Langerhans Cell Histiocytosis. SHILAP Revista de lepidopterología. 2021. 1–6. 3 indexed citations
18.
Farrugia, Mark, et al.. (2016). Candida meningitis in an immunocompetent patient detected through (1→3)-beta-d-glucan. International Journal of Infectious Diseases. 51. 25–26. 12 indexed citations
19.
Farrugia, Mark, et al.. (2011). A Rare Case of Chronic Alcoholism Related Marchiafava-Bignami Disease. Journal of Neurology Research. 1(4). 168–169. 1 indexed citations
20.
Farrugia, Mark, et al.. (1997). Perforation of the Esophagus Secondary to Insertion of Covered Wallstent Endoprostheses. CardioVascular and Interventional Radiology. 20(6). 470–472. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Moon‐Sing Lee Breakdown of academic impact, for papers by Rangesh Kunnavakkam Breakdown of academic impact, for papers by Shaleen Kumar Breakdown of academic impact, for papers by Michelle Echevarria Breakdown of academic impact, for papers by C. Nutting Breakdown of academic impact, for papers by Sandra Ventorin von Zeidler Breakdown of academic impact, for papers by Yanming Jiang Breakdown of academic impact, for papers by Jeffrey Straub Breakdown of academic impact, for papers by Jerzy Wydmański Breakdown of academic impact, for papers by Olgun Eliçin
Rankless by CCL
2026